Skip to content
CompanySight
Sign in
Company No. 04662060 · Incorporated 11 Feb 2003

London Pharma & Chemicals Group Ltd

Registered name: LONDON PHARMA & CHEMICALS GROUP LTD

Part of London Pharma & Chemicals Holdings Ltd group

London Pharma & Chemicals Group Ltd made £687k revenue and £956k profit in the year to 31 Dec 2025. read from filing text

London Pharma & Chemicals Group Ltd’s revenue grew 17% to £687k in the year to 31 Dec 2025, with £956k profit and 8 employees. The company is classified under “bookkeeping activities” and is based in Borehamwood; we hold 4 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 69202Bookkeeping activitiesSIC 70100Activities of head officesSIC 70221Financial management
Status
Active
Location
Borehamwood, East of England
Age
23 yrs · since 2003
Type
Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company's ultimate parent company is London Pharma & Chemicals Holdings Ltd, a company registered in England and Wales. The registered office is Unit 10, Delta Court, Manor Way, Borehamwood, Hertf”

Latest accounts · year to 31 Dec 2025

Key figures

Small teamOperating leverageCash flow filed
Revenue
£687k
Growth ▲17.1%
Profit
£956k
Growth ▲153.7%
Profit margin
139.1%
 
Employees
8
Change ▲14.3%
Profit / employee
£119k
Revenue/employee £85.9k
Profitable streak
4yrs
Consecutive profitable years in our data

Unusual figures. Profit is higher than revenue in this filing. That usually means investment income, dividends from subsidiaries or one-off gains — or a mis-tagged figure. Check the original filing before drawing conclusions.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to31 Dec 202231 Dec 202331 Dec 202431 Dec 2025
DisclosureFull P&Lread from filing textFull P&Lread from filing textFull P&Lread from filing textFull P&Lread from filing text
Profit & loss
Revenue (turnover)£453k£662k£587k£687k
Operating profit−£388k−£200k−£909k−£313k
Profit before tax£4.7m£979k£345k£1.1m
Profit after tax£4.8m£989k£377k£956k
Profit (best available)£4.8m£989k£377k£956k
Staff costs£525k£724k£775k£663k
Employees (average)9878
Ratios
Profit margin1050%149.4%64.2%139.1%
Revenue per employee£50.3k£82.7k£83.9k£85.9k
Profit per employee£528k£124k£53.8k£119k
Growth (year on year)
Revenue growth—▲46.2%▼11.3%▲17.1%
Profit growth—▼79.2%▼61.9%▲153.7%
Headcount growth—▼11.1%▼12.5%▲14.3%
Balance sheet — indirect signals, not revenue
Cash at bank£14.1m£16.4m£17.4m£19.2m
Net assets£21.7m£22.7m£23.1m£24.1m
Fixed assets£11.1m£10.8m£12.2m£12.3m
Current assets£19.6m£24m£23.3m£25.5m
Debtors£4.4k£2.1k£504£6.2k
Deferred income£243k£478k£239k£204k
Cash from operations£3.1m−£663k−£1.1m−£676k
SourceFullAccounts · bulk data Sep 2024FullAccounts · bulk data Sep 2024FullAccounts · bulk data Sep 2025FullAccounts · bulk data Sep 2026
Derived from the latest filing

How the business works

Profit margin
139.1%
Profit ÷ revenue.
Gross margin
—
Gross profit ÷ revenue. High for software and services.
Revenue per employee
£85.9k
Revenue ÷ average employees.
Profit per employee
£119k
Profit ÷ average employees.
Cash conversion
—
Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue
1783%
Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue
29.8%
Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue
0.9%
Money owed by customers. Low = customers pay quickly.
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
▲4%
Now £24.1m
Cash at bank
▲10%
Now £19.2m
Headcount
▲14%
Now 8
Deferred income
▼15%
Now £204k
Fixed assets
▲1%
Now £12.3m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. London Pharma & Chemicals Holdings Ltdultimate parent75–100%
  2. London Pharma & Chemicals Group Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Subsidiaries (9)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £956k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.